These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23918241)

  • 21. Mir-595 is a significant indicator of poor patient prognosis in epithelial ovarian cancer.
    Zhou QH; Zhao YM; Jia LL; Zhang Y
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4278-4282. PubMed ID: 29077170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.
    Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y
    Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma.
    Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M
    J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer.
    Hong F; Li Y; Xu Y; Zhu L
    J Int Med Res; 2013 Feb; 41(1):64-71. PubMed ID: 23569131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features.
    Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G
    Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential MicroRNA Expression Profiles in Primary and Recurrent Epithelial Ovarian Cancer.
    Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Lee YS; Cho YL
    Anticancer Res; 2015 May; 35(5):2611-7. PubMed ID: 25964536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Expression of MicroRNA-200a/b Indicates Potential Diagnostic and Prognostic Biomarkers in Epithelial Ovarian Cancer.
    Zhang B; Li Y; Li Y; Zhao H; An R
    Dis Markers; 2022; 2022():2751696. PubMed ID: 35371343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
    Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
    Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival.
    Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H
    Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
    Ma Z; Wang X; He J; Xia J; Li Y
    PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.
    Wan WN; Zhang YQ; Wang XM; Liu YJ; Zhang YX; Que YH; Zhao WJ; Li P
    Diagn Pathol; 2014 Sep; 9():178. PubMed ID: 25257702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-23b is an independent prognostic marker and suppresses ovarian cancer progression by targeting runt-related transcription factor-2.
    Li W; Liu Z; Chen L; Zhou L; Yao Y
    FEBS Lett; 2014 May; 588(9):1608-15. PubMed ID: 24613919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
    Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
    Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients.
    Meng X; Joosse SA; Müller V; Trillsch F; Milde-Langosch K; Mahner S; Geffken M; Pantel K; Schwarzenbach H
    Br J Cancer; 2015 Nov; 113(9):1358-66. PubMed ID: 26393886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of LncRNA BANCR and its prognostic significance in human epithelial ovarian cancer.
    Xu X; Pan L; Zhuo M; Yang X; Zhang W; Sun D; Zeng N; Zhang D
    Eur J Gynaecol Oncol; 2017; 38(3):449-452. PubMed ID: 29693889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma.
    Li X; Pan Q; Wan X; Mao Y; Lu W; Xie X; Cheng X
    BMC Cancer; 2015 Jul; 15():509. PubMed ID: 26152689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-215 functions as a tumor suppressor in epithelial ovarian cancer through regulation of the X-chromosome-linked inhibitor of apoptosis.
    Ge G; Zhang W; Niu L; Yan Y; Ren Y; Zou Y
    Oncol Rep; 2016 Mar; 35(3):1816-22. PubMed ID: 26676658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of miR-1294 associates with prognosis and tumor progression in epithelial ovarian cancer.
    Guo TY; Xu HY; Chen WJ; Wu MX; Dai X
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7646-7652. PubMed ID: 30536306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.